08:30
|
10:10

1

Opening
Ceremony

&

Keynote
Forum

Track 2-5:

Infectious Immunology, Immunity and Vaccinology

Track 2-24:

Computer Aided Structure Based Vaccine Design

Track 3-16:

Vaccine Development for Severe Gastrointestinal Disorders & Enteric Infectious Diseases

Track 6-3:

Livestock Vaccines

2

Track 2-6:

Advances in Molecular and Cell Vaccinology

Track 2-25:

Chemistry in Vaccine Design and Development

Track 3-17:

Vaccine Development for Cardiovascular Diseases

Track 6-4:

Respiratory and other Zoonosis Diseases in Goats, Sheep, Pig and Cattle

3

Track 2-7:

Immunogenetics, Molecular Genetics and Vaccinology

Track 2-26:

Cytokine Networks in Vaccine Design

Track 3-18:

Vaccination and/against CNS Disorder

Track 6-5:

Tech Advances in Agricultural/
Aquaculture Vaccine Development

4

Track 2-8:

Pharmacology and Vaccinology

Track 2-27:

Track 3-19:

Vaccine Development for Hematological/
Blood Diseases

Track 6-6:

Economic Fish Vaccine Development and Market

Track 3:
Human Preventive and Therapeutic Vaccines-Future Vaccines

5

Track 2-9:

Applied Toxicology in Vaccinology

Track 3-1:

Rational Applications of Vaccines for Different Disease States

Track 3-20:

Vaccination-based Therapies in Osteoporosis, Arthritis and rheumatism, and Lyme Diseases

Track 6-7:

Vaccines for Shell Fishes

10:10
|
10:30

6

Track 7:
Vaccine Production Tech and Manufactur-
ing Strategies

Track 2-10:

Molecular Microbiology/
Virology, and Cell Biology in Vaccinology

Track 3-2:

Research Progress of HIV Vaccination

Track 3-21:

Antigen-specific Immunotherapy and New Vaccine Approaches for Allergies

Track 7-1:

Vaccine Bioprocess Technologies

10:30
|
12:10

7

Track 2-11:

Pathology, Pathobiology and Hepatology/Liver Diseases in Vaccinology

Track 3-3:

Anti-HIV Vaccine Discovery and Development

Track 3-22:

Vaccine Development for Autoimmune Diseases

Track 7-2:

DNA Vaccine Production Technologies

8

Track 4:
Other Human Vaccine Development

Track 2-12:

Vaccine Endocrinology in Vaccinology

Track 3-4:

Anti HBV Vaccine Design and Development for the Resistant Strains

Track 4-1:

Vaccines against Major Virally caused Sexually Transmitted Diseases

Track 7-3:

Protein Related Vaccine Manufacturing Strategies

9

Track 2-13:

Effective Lab Animal Models in Vaccinology

Track 3-5:

Anti HCV Vaccine Discovery and Development

Track 4-2:

Anti-fertility or Controceptive Vaccines

Track 7-4:

Outsourcing Off-Site GMP Vaccine Production under Ensured QA/QC and PAT

10

Track 8:
International Business & Market Development

Track 2-14:

Evidence-based Vaccinology (EBV)

Track 3-6:

Lessons Learned from Developing the HPV vaccine

Track 4-3:

Progress Made on Vaccines against Addiction

Track 8-1:

Introduction to Vaccine Pipeline and Recent Launched Vaccines

12:10
|
13:30

Lunch Break

13:30
|
17:10

1

Track 1:
Public Health, Economics, Safety/Ethic and Policy of Vaccination

Track 1-1:

Public Health and New Vaccines Developed in Asia and other Developing Countries

Track 2-15:

Ecology, Entomology, Parasitology, Plant Biology and Vaccinology

Track 3-7:

Vaccine Development against Dengue Fever

Track 4-4:

Vaccine Development against Bioterrorism

Track 8-2:

Early and Late Stage Vaccine Inventors Look for Investment

2

Track 5:
Vaccine R & D for Emerging Infectious Diseases

Track 1-2:

Etiology, Epidemiology and Public Urgent Preparedness

Track 2-16:

Emerging Vaccine Development Technologies

Track 3-8:

Vaccines for Other Severe Viral Infections

Track 5-1:

Influenza, Avian Flu, and SARS Vaccine Development

Track 8-3:

Investors Look for Vaccine Technologies and Products

3

Track 1-3:

Safety Issues at Individual and Population Level toward Public Acceptance

Track 2-17:

DNA Based Vaccines and Technologies

Track 3-9:

Vaccine Design against Microbial Pathogens and Severe Bacterial Infections

Track 5-2:

TB Vaccine Development: Opportunity and Imperative

4

Track 1-4:

Regulatory/Policy, Economics, and IP Issues of Vaccine Program Implementation

Track 2-18:

Adjuvants, Imunopotentiators and Vaccines

Track 3-10:

Tumor Immunology, Immunotherapy with Cancer Vaccines

Track 5-3:

Malaria Vaccine Development

5

Track 1-5:

Vaccine Technology Transfer in Resource Deficient Countries

Track 2-19:

Innate Immunity and Novel Vaccines

Track 3-11:

Advances in Cancer Vaccine Technology

Track 5-4:

Vaccine Discovery and Development against other Emerging Infectious Diseases

6

Track 2-1:

Immunogenetics, Molecular Genetics, Functional Genomics and Reverse Vaccinology

Track 2-20:

Mucosal Immunity and Vaccine Design

Track 3-12:

Vaccine R & D against Susceptible Cancers

Track 5-5:

Vaccines Against other Parasitic Disorders

7

Track 2-2:

Other Omics in Vaccinology

Track 2-21:

New Advances in Viral Vaccine Vector Development

Track 3-13:

Cancer Vaccine Pipeline and Market Evaluation

Track 5-6:

Vaccine against other Resistant and Multi-Resistant Pathogens

8

Track 6:
Livestock/
Veterinary/ Aquaculture Vaccine
R & D

Track 2-3:

Computational Vaccinology: Bioinformatics, Structural Biology and Immunogen Design

Track 2-22:

Current Breakthrough in Cellular Vaccines

Track 3-14:

Demand on Development of the Technology and Oversight Issues for Very Rapid Vaccines

Track 6-1:

Veterinary and Aquatic Vaccinology

9

Track 2-4:

RNA Interference: A New Frontier in Vaccinology

Track 2-23:

Peptide Based Vaccines and Peptide MHC Interactions to Aid in Better Vaccines

Track 3-15:

Progress from Orphan, Nuclear Irradiated Vaccines or Prophylactic to Therapeutic Vaccines

Track 6-2:

Latest Breakthrough in Veterinary Vaccine Development

10

Workshop 2:

Public Acceptance and Ethic Issues for Vaccine Clinical Trials

Workshop 3:

How to Enhance Successful Safety and Efficacy of Recombinant Viral Vaccines

Workshop 4:

Beyond Phase III Trials: Phase IV Vaccine Evaluations

Workshop 5

How Target at the Vaccines against Nococomial Infections